NO780395L - Oksadiazolpyrimidin-derivater. - Google Patents
Oksadiazolpyrimidin-derivater.Info
- Publication number
- NO780395L NO780395L NO780395A NO780395A NO780395L NO 780395 L NO780395 L NO 780395L NO 780395 A NO780395 A NO 780395A NO 780395 A NO780395 A NO 780395A NO 780395 L NO780395 L NO 780395L
- Authority
- NO
- Norway
- Prior art keywords
- pyrimidine
- oxadiazole
- oxo
- carbamate
- piperidino
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 32
- -1 1,2,5,6-tetrahydropyridin-1-yl Chemical class 0.000 claims description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 24
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 claims description 24
- 125000000217 alkyl group Chemical group 0.000 claims description 21
- 150000003839 salts Chemical class 0.000 claims description 21
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 14
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 13
- 125000003118 aryl group Chemical group 0.000 claims description 13
- 125000001188 haloalkyl group Chemical group 0.000 claims description 12
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 10
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- AISBEICRFWVOOH-UHFFFAOYSA-N 1-cyclononyl-2-piperidin-1-ylazonane Chemical class N1(CCCCC1)C1N(CCCCCCC1)C1CCCCCCCC1 AISBEICRFWVOOH-UHFFFAOYSA-N 0.000 claims description 6
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 6
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- LYVFEKDYURJTBE-UHFFFAOYSA-N N1=CN=CC=C1.O1N=NC=C1 Chemical class N1=CN=CC=C1.O1N=NC=C1 LYVFEKDYURJTBE-UHFFFAOYSA-N 0.000 claims description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 231100000252 nontoxic Toxicity 0.000 claims 1
- 230000003000 nontoxic effect Effects 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 99
- 239000000203 mixture Substances 0.000 description 46
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 27
- 238000002844 melting Methods 0.000 description 26
- 230000008018 melting Effects 0.000 description 26
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical class [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 22
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 21
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 239000012071 phase Substances 0.000 description 19
- 238000006243 chemical reaction Methods 0.000 description 16
- 239000002244 precipitate Substances 0.000 description 15
- 239000002904 solvent Substances 0.000 description 14
- 238000000354 decomposition reaction Methods 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 239000007858 starting material Substances 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 239000012300 argon atmosphere Substances 0.000 description 9
- 239000000725 suspension Substances 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 239000002585 base Substances 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 235000011121 sodium hydroxide Nutrition 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 6
- DOYINGSIUJRVKA-UHFFFAOYSA-N 6-chloro-3-hydroxy-2-iminopyrimidin-4-amine Chemical compound NC1=CC(Cl)=NC(=N)N1O DOYINGSIUJRVKA-UHFFFAOYSA-N 0.000 description 5
- ZNECNPWXEVORDM-UHFFFAOYSA-N COC(=O)NC1=CC(Cl)=NC(NC(=O)OC)=[N+]1[O-] Chemical compound COC(=O)NC1=CC(Cl)=NC(NC(=O)OC)=[N+]1[O-] ZNECNPWXEVORDM-UHFFFAOYSA-N 0.000 description 5
- 239000008346 aqueous phase Substances 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 239000011877 solvent mixture Substances 0.000 description 5
- 229920002261 Corn starch Polymers 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical class [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 4
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 4
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 4
- 239000008120 corn starch Substances 0.000 description 4
- 229940099112 cornstarch Drugs 0.000 description 4
- 229910052736 halogen Inorganic materials 0.000 description 4
- 150000002367 halogens Chemical class 0.000 description 4
- 239000012442 inert solvent Substances 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- 238000005809 transesterification reaction Methods 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- ADSNTUKNIHVUSH-UHFFFAOYSA-N 6-(3,6-dihydro-2h-pyridin-1-yl)-3-hydroxy-2-iminopyrimidin-4-amine Chemical compound N=C1N(O)C(N)=CC(N2CC=CCC2)=N1 ADSNTUKNIHVUSH-UHFFFAOYSA-N 0.000 description 3
- YDCMOGDKEZHNJZ-UHFFFAOYSA-N CCOC(=O)NC1=[N+]([O-])C(NC(=O)OCC)=CC(N2CCCCC2)=N1 Chemical compound CCOC(=O)NC1=[N+]([O-])C(NC(=O)OCC)=CC(N2CCCCC2)=N1 YDCMOGDKEZHNJZ-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000004945 aromatic hydrocarbons Chemical group 0.000 description 3
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 3
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 3
- 150000007529 inorganic bases Chemical class 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- QJIUMVUZDYPQRT-UHFFFAOYSA-N 6-chloro-2,4-pyrimidinediamine Chemical compound NC1=CC(Cl)=NC(N)=N1 QJIUMVUZDYPQRT-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VUHHJXZIOHSRQK-UHFFFAOYSA-N C1=C(N2CC=CCC2)N=C(NC(=O)OCC=2C=CC=CC=2)[N+]([O-])=C1NC(=O)OCC1=CC=CC=C1 Chemical compound C1=C(N2CC=CCC2)N=C(NC(=O)OCC=2C=CC=CC=2)[N+]([O-])=C1NC(=O)OCC1=CC=CC=C1 VUHHJXZIOHSRQK-UHFFFAOYSA-N 0.000 description 2
- SUVYXRKPIWWYJT-UHFFFAOYSA-N CCOC(=O)NC1=CC(N(C)C)=NC(NC(=O)OCC)=[N+]1[O-] Chemical compound CCOC(=O)NC1=CC(N(C)C)=NC(NC(=O)OCC)=[N+]1[O-] SUVYXRKPIWWYJT-UHFFFAOYSA-N 0.000 description 2
- RUEPIYNETDTHLI-UHFFFAOYSA-N CCOC(=O)NC1=[N+]([O-])C(NC(=O)OCC)=CC(N2CC3CCC(CC3)C2)=N1 Chemical compound CCOC(=O)NC1=[N+]([O-])C(NC(=O)OCC)=CC(N2CC3CCC(CC3)C2)=N1 RUEPIYNETDTHLI-UHFFFAOYSA-N 0.000 description 2
- SFDATPIECHEWBM-UHFFFAOYSA-N COC(=O)NC1=[N+]([O-])C(NC(=O)OC)=CC(N2CC=CC2)=N1 Chemical compound COC(=O)NC1=[N+]([O-])C(NC(=O)OC)=CC(N2CC=CC2)=N1 SFDATPIECHEWBM-UHFFFAOYSA-N 0.000 description 2
- FGBXMFOMDSSESH-UHFFFAOYSA-N COC(=O)NC1=[N+]([O-])C(NC(=O)OC)=CC(N2CCC(O)CC2)=N1 Chemical compound COC(=O)NC1=[N+]([O-])C(NC(=O)OC)=CC(N2CCC(O)CC2)=N1 FGBXMFOMDSSESH-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 2
- 239000000920 calcium hydroxide Substances 0.000 description 2
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229940050176 methyl chloride Drugs 0.000 description 2
- BKIMMITUMNQMOS-UHFFFAOYSA-N nonane Chemical compound CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 235000011118 potassium hydroxide Nutrition 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 230000035488 systolic blood pressure Effects 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 230000007306 turnover Effects 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- QUIJMHDIAFOPRK-UHFFFAOYSA-N 1-cyclooctylazocane Chemical compound C1CCCCCCC1N1CCCCCCC1 QUIJMHDIAFOPRK-UHFFFAOYSA-N 0.000 description 1
- LJCZNYWLQZZIOS-UHFFFAOYSA-N 2,2,2-trichlorethoxycarbonyl chloride Chemical compound ClC(=O)OCC(Cl)(Cl)Cl LJCZNYWLQZZIOS-UHFFFAOYSA-N 0.000 description 1
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- CJQNJRRDTPULTL-UHFFFAOYSA-N 3-azabicyclo[3.2.1]octane Chemical compound C1C2CCC1CNC2 CJQNJRRDTPULTL-UHFFFAOYSA-N 0.000 description 1
- LICHZOBEUWVYSY-UHFFFAOYSA-N 3-azabicyclo[3.2.2]nonane Chemical compound C1CC2CCC1CNC2 LICHZOBEUWVYSY-UHFFFAOYSA-N 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- JVQIKJMSUIMUDI-UHFFFAOYSA-N 3-pyrroline Chemical compound C1NCC=C1 JVQIKJMSUIMUDI-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- FNNRJAJMCKOOPN-UHFFFAOYSA-N CC(C)COC(=O)NC1=[N+]([O-])C(NC(=O)OCC(C)C)=CC(N2CCCCC2)=N1 Chemical compound CC(C)COC(=O)NC1=[N+]([O-])C(NC(=O)OCC(C)C)=CC(N2CCCCC2)=N1 FNNRJAJMCKOOPN-UHFFFAOYSA-N 0.000 description 1
- LTDTXKAEJZGWAB-UHFFFAOYSA-N CCCCOC(=O)NC1=[N+]([O-])C(NC(=O)OCCCC)=CC(N2CCCCC2)=N1 Chemical compound CCCCOC(=O)NC1=[N+]([O-])C(NC(=O)OCCCC)=CC(N2CCCCC2)=N1 LTDTXKAEJZGWAB-UHFFFAOYSA-N 0.000 description 1
- RSPOUEGMHANQEM-UHFFFAOYSA-N COC(=O)NC1=[N+]([O-])C(NC(=O)OC)=CC(N2CC(O)CCC2)=N1 Chemical compound COC(=O)NC1=[N+]([O-])C(NC(=O)OC)=CC(N2CC(O)CCC2)=N1 RSPOUEGMHANQEM-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 241000978776 Senegalia senegal Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 235000009233 Stachytarpheta cayennensis Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- LORCZWNRTOKHKK-UHFFFAOYSA-N [O-][N+](C(NC(O)=O)=C1)=C(NC(O)=O)N=C1Cl Chemical compound [O-][N+](C(NC(O)=O)=C1)=C(NC(O)=O)N=C1Cl LORCZWNRTOKHKK-UHFFFAOYSA-N 0.000 description 1
- BBJZXTNWLFVPJQ-UHFFFAOYSA-N [O-][N+](C(NC(O)=O)=C1)=C(NC(O)=O)N=C1N1CC=CCC1 Chemical compound [O-][N+](C(NC(O)=O)=C1)=C(NC(O)=O)N=C1N1CC=CCC1 BBJZXTNWLFVPJQ-UHFFFAOYSA-N 0.000 description 1
- WQYGHYQDLILLEO-UHFFFAOYSA-N [O-][N+]1=C(NC(O)=O)N=CC=C1NC(O)=O Chemical compound [O-][N+]1=C(NC(O)=O)N=CC=C1NC(O)=O WQYGHYQDLILLEO-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000005011 alkyl ether group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 125000005265 dialkylamine group Chemical group 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 125000005059 halophenyl group Chemical group 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229940078552 o-xylene Drugs 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- BIWOSRSKDCZIFM-UHFFFAOYSA-N piperidin-3-ol Chemical compound OC1CCCNC1 BIWOSRSKDCZIFM-UHFFFAOYSA-N 0.000 description 1
- HDOWRFHMPULYOA-UHFFFAOYSA-N piperidin-4-ol Chemical compound OC1CCNCC1 HDOWRFHMPULYOA-UHFFFAOYSA-N 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000011699 spontaneously hypertensive rat Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- 125000005270 trialkylamine group Chemical group 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT74577A AT351037B (de) | 1977-02-04 | 1977-02-04 | Verfahren zur herstellung von neuen oxadiazolo- pyrimidinderivaten und deren salzen |
| LU7778640A LU78640A1 (xx) | 1977-02-04 | 1977-12-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO780395L true NO780395L (no) | 1978-08-07 |
Family
ID=25593802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO780395A NO780395L (no) | 1977-02-04 | 1978-02-03 | Oksadiazolpyrimidin-derivater. |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US4150131A (xx) |
| JP (1) | JPS6026115B2 (xx) |
| AU (1) | AU515104B2 (xx) |
| BE (1) | BE863609A (xx) |
| CA (1) | CA1096862A (xx) |
| CH (1) | CH638216A5 (xx) |
| DE (1) | DE2804519A1 (xx) |
| DK (1) | DK50778A (xx) |
| ES (2) | ES466590A1 (xx) |
| FI (1) | FI62310C (xx) |
| FR (1) | FR2383931A1 (xx) |
| GB (2) | GB1566673A (xx) |
| GR (1) | GR71603B (xx) |
| HU (1) | HU178012B (xx) |
| IE (1) | IE46320B1 (xx) |
| IL (2) | IL53926A (xx) |
| IT (1) | IT1092333B (xx) |
| MC (1) | MC1184A1 (xx) |
| NL (1) | NL7801289A (xx) |
| NO (1) | NO780395L (xx) |
| NZ (1) | NZ186335A (xx) |
| PT (1) | PT67615B (xx) |
| SE (1) | SE7801312L (xx) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1103245A (en) * | 1978-07-21 | 1981-06-16 | Jean-Claude Muller | Process for the manufacture of novel oxadiazolopyrimidine derivatives |
| NZ190915A (en) * | 1978-07-31 | 1984-07-31 | Hoffmann La Roche | Oxadiazolotriazine derivatives and pharmaceutical compositions |
| US4316901A (en) * | 1980-06-23 | 1982-02-23 | The Upjohn Company | Animal feed and process |
| US4307093A (en) * | 1980-06-23 | 1981-12-22 | The Upjohn Company | Animal feed and process |
| DK148826C (da) * | 1980-12-19 | 1986-03-24 | Hoffmann La Roche | Analogifremgangsmaade til fremstilling af oxadiazolopyrimidinderivater eller salte deraf med baser og pyrimidinderivat til anvendelse som mellemprodukt ved denne fremgangsmaade |
| US4411690A (en) * | 1981-01-26 | 1983-10-25 | E. I. Du Pont De Nemours & Co. | Fused [1,2,4]oxadiazolylidenebenzenesulfonamides and their use as herbicides and plant growth regulants |
| CH649291A5 (de) * | 1982-03-16 | 1985-05-15 | Hoffmann La Roche | Dicarbamate. |
| EP0187854A4 (en) * | 1984-07-13 | 1987-01-22 | Gail S Bazzano | SUBSTITUTED PYRIMIDINE OXIDES USEFUL FOR PROMOTING HAIR GROWTH. |
| HU196061B (en) * | 1986-07-10 | 1988-09-28 | Richter Gedeon Vegyeszet | Process for production of pirimidine-derivatives |
| LU86547A1 (fr) * | 1986-08-07 | 1988-03-02 | Oreal | Suspension pour induire et stimuler la croissance des cheveux et diminuer leur chute a base de derives de la pyrimidine |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3461461A (en) * | 1965-11-01 | 1969-08-12 | Upjohn Co | 6-amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidines |
| DE2118261A1 (de) * | 1971-04-15 | 1972-11-02 | C.H. Boehringer Sohn, 6507 Ingelheim | Neue N-haltige Bicyclen, deren Säureadditionssalze sowie Verfahren zu deren Herstellung |
| BE786028A (fr) * | 1971-07-08 | 1973-01-08 | Boehringer Sohn Ingelheim | 2,3-dihydro-oxo-imidazo(1,2-a)-pyrimidines, leurs sels d'addition avec des acides et procedes pour les fabriquer |
| BE790008A (fr) * | 1971-10-15 | 1973-04-12 | Fmc Corp | Nouveaux composes herbicides |
| DE2210633C2 (de) * | 1972-03-06 | 1983-09-22 | Bayer Ag, 5090 Leverkusen | Kondensierte Pyridinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| DE2252122A1 (de) * | 1972-10-24 | 1974-04-25 | Hoechst Ag | Oxazolo-chinazoline und verfahren zu ihrer herstellung |
| DE2253555A1 (de) * | 1972-11-02 | 1974-05-09 | Hoechst Ag | Oxazolo-pyrimidine und verfahren zu ihrer herstellung |
| US3910928A (en) * | 1974-04-26 | 1975-10-07 | Upjohn Co | 3-(Cyanimino)-propionitriles |
-
1978
- 1978-01-10 CH CH22878A patent/CH638216A5/de not_active IP Right Cessation
- 1978-01-23 CA CA295,439A patent/CA1096862A/en not_active Expired
- 1978-01-27 NZ NZ186335A patent/NZ186335A/xx unknown
- 1978-01-27 US US05/873,183 patent/US4150131A/en not_active Expired - Lifetime
- 1978-01-30 IL IL53926A patent/IL53926A/xx unknown
- 1978-01-30 IE IE198/78A patent/IE46320B1/en unknown
- 1978-01-30 HU HU78HO2047A patent/HU178012B/hu unknown
- 1978-01-30 IT IT19785/78A patent/IT1092333B/it active
- 1978-01-31 AU AU32858/78A patent/AU515104B2/en not_active Expired
- 1978-02-02 MC MC781281A patent/MC1184A1/xx unknown
- 1978-02-02 DE DE19782804519 patent/DE2804519A1/de active Granted
- 1978-02-02 JP JP53009965A patent/JPS6026115B2/ja not_active Expired
- 1978-02-02 FI FI780344A patent/FI62310C/fi not_active IP Right Cessation
- 1978-02-03 SE SE7801312A patent/SE7801312L/xx unknown
- 1978-02-03 DK DK50778A patent/DK50778A/da not_active Application Discontinuation
- 1978-02-03 GB GB2537/79A patent/GB1566673A/en not_active Expired
- 1978-02-03 ES ES466590A patent/ES466590A1/es not_active Expired
- 1978-02-03 GB GB4449/78A patent/GB1566672A/en not_active Expired
- 1978-02-03 NL NL7801289A patent/NL7801289A/xx not_active Application Discontinuation
- 1978-02-03 BE BE184861A patent/BE863609A/xx unknown
- 1978-02-03 NO NO780395A patent/NO780395L/no unknown
- 1978-02-03 PT PT67615A patent/PT67615B/pt unknown
- 1978-02-22 GR GR55336A patent/GR71603B/el unknown
- 1978-07-10 FR FR7820486A patent/FR2383931A1/fr active Granted
- 1978-09-29 ES ES473787A patent/ES473787A1/es not_active Expired
-
1980
- 1980-03-25 IL IL59713A patent/IL59713A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES473787A1 (es) | 1979-05-16 |
| IT1092333B (it) | 1985-07-06 |
| FI62310B (fi) | 1982-08-31 |
| IL53926A0 (en) | 1978-04-30 |
| MC1184A1 (fr) | 1978-12-22 |
| JPS5398993A (en) | 1978-08-29 |
| IT7819785A0 (it) | 1978-01-30 |
| ES466590A1 (es) | 1978-10-01 |
| IL53926A (en) | 1980-12-31 |
| GB1566672A (en) | 1980-05-08 |
| DE2804519A1 (de) | 1978-08-10 |
| CH638216A5 (de) | 1983-09-15 |
| US4150131A (en) | 1979-04-17 |
| HU178012B (en) | 1982-02-28 |
| IE780198L (en) | 1978-08-04 |
| PT67615B (en) | 1980-03-03 |
| GR71603B (xx) | 1983-06-17 |
| DK50778A (da) | 1978-08-05 |
| FR2383931A1 (fr) | 1978-10-13 |
| BE863609A (fr) | 1978-08-03 |
| FI62310C (fi) | 1982-12-10 |
| IE46320B1 (en) | 1983-05-04 |
| SE7801312L (sv) | 1978-08-05 |
| FI780344A (fi) | 1978-08-05 |
| FR2383931B1 (xx) | 1980-07-25 |
| NL7801289A (nl) | 1978-08-08 |
| CA1096862A (en) | 1981-03-03 |
| GB1566673A (en) | 1980-05-08 |
| PT67615A (en) | 1978-03-01 |
| IL59713A0 (en) | 1980-06-30 |
| DE2804519C2 (xx) | 1990-06-13 |
| JPS6026115B2 (ja) | 1985-06-21 |
| AU3285878A (en) | 1979-08-09 |
| NZ186335A (en) | 1980-04-28 |
| AU515104B2 (en) | 1981-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20040087335A (ko) | 질소 함유 복소환 화합물 | |
| KR101171433B1 (ko) | 이미다졸리딘온 유도체 | |
| NO156385B (no) | Anordning for laasing av dreibare maskinelementer. | |
| EA011086B1 (ru) | Производные пролина и их применение в качестве ингибиторов дипептидилпептидазы iv | |
| NO780395L (no) | Oksadiazolpyrimidin-derivater. | |
| Höhn et al. | Potential antidiabetic agents. Pyrazolo [3, 4-b] pyridines | |
| EP0003016B1 (en) | Pyrazino-benzoxazepine and -benzthiazepine derivatives, processes for their production and pharmaceutical compositions containing them | |
| NO792412L (no) | Fremgangsmaate ved fremstilling av nye oxadiazolopyrimidinederivater | |
| US3681360A (en) | Antiviral substituted acridanones | |
| US6355647B1 (en) | 3-substituted 3,4,5,7-tetrahedropyrrolo[3′,4′:4,5]thieno-[2,3-d]pyrimidine derivatives, their preparation and use | |
| AU8545091A (en) | Antiproliferative substituted naphthalene compounds | |
| NO780396L (no) | Oksadiazolpyrimidin-derivater. | |
| NO146470B (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive nye 6-fenyl-s-triazolo-(4,3-a)-pyrido-(2,3-f)-(1,4)-diazepiner | |
| NO174712B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser | |
| US3847923A (en) | N-(1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carbonyloxy)succinimide and glutarimide | |
| NO852663L (no) | Fremgangsmaate ved fremstilling av 3-aminocarbonylmethoxy-5-fenylpyrazol-forbindelser. | |
| NO327549B1 (no) | Benzo[G]kinolinderivater for behandling av glaukom og myopi | |
| RU2057754C1 (ru) | Гетероциклические соединения или их кислотно-аддитивные соли | |
| US4175190A (en) | 6-Chloro-2,4-pyrimidine-dicarbamate-3-oxides | |
| US4176119A (en) | 2,4-Pyrimidine-dicarbamate-3-oxides | |
| PT97570A (pt) | Processo para a preparacao de derivados de benzotienopiridina | |
| NO153850B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive guanidiner. | |
| NO862541L (no) | Nye tieno-1,2-tiazolderivater og fremgangsmaate til fremstilling derav. | |
| KR810001973B1 (ko) | 옥사디아졸로 피리미딘 유도체의 제조방법 | |
| JP2010105951A (ja) | ６−アルキル置換テトラヒドロピリド［４，３−ｄ］ピリミジン誘導体 |